{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:16:55Z","timestamp":1791357415393,"version":"4.3.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","psychosomaticsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychosomatics"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.psym.2018.03.002","type":"journal-article","created":{"date-parts":[[2018,3,21]],"date-time":"2018-03-21T23:30:03Z","timestamp":1521675003000},"page":"496-505","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Use of a Gabapentin Protocol for the Management of Alcohol Withdrawal: A Preliminary Experience Expanding From the Consultation-Liaison Psychiatry Service"],"prefix":"10.1016","volume":"59","author":[{"given":"Jonathan G.","family":"Leung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela B.","family":"Rakocevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliot M.","family":"Handler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno A.","family":"Perossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin L.","family":"Borreggine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy L.","family":"Stark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah K.","family":"Betcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel K.","family":"Hosker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaine A.","family":"Minton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Braus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross A.","family":"Dierkhising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemuel L.","family":"Philbrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.psym.2018.03.002_bib1","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMra1407298","article-title":"Recognition and management of withdrawal delirium (delirium tremens)","volume":"371","author":"Schuckit","year":"2014","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.psym.2018.03.002_bib2","first-page":"1443","article-title":"Alcohol withdrawal syndrome","volume":"69","author":"Bayard","year":"2004","journal-title":"Am Fam Physician"},{"issue":"10","key":"10.1016\/j.psym.2018.03.002_bib3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1001\/archinte.162.10.1117","article-title":"Symptom-triggered vs fixed-schedule doses of benzodiazepine for alcohol withdrawal: a randomized treatment trial","volume":"162","author":"Daeppen","year":"2002","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.psym.2018.03.002_bib4","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1001\/jama.1994.03520070039035","article-title":"Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial","volume":"272","author":"Saitz","year":"1994","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.psym.2018.03.002_bib5","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4065\/83.3.274","article-title":"Inappropriate use of symptom-triggered therapy for alcohol withdrawal in the general hospital","volume":"83","author":"Hecksel","year":"2008","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.psym.2018.03.002_bib6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1176\/appi.psy.45.3.256","article-title":"False positives on the clinical institute withdrawal assessment for alcohol-revised: is this scale appropriate for use in the medically ill?","volume":"45","author":"Bostwick","year":"2004","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1016\/j.psym.2018.03.002_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcrc.2013.11.016","article-title":"Influence of dexmedetomidine therapy on the management of severe alcohol withdrawal syndrome in critically ill patients","volume":"29","author":"Frazee","year":"2014","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.psym.2018.03.002_bib8","first-page":"24","article-title":"Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin","volume":"3","author":"Malcolm","year":"2007","journal-title":"J Clin Sleep Med"},{"issue":"4","key":"10.1016\/j.psym.2018.03.002_bib9","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40265-015-0358-1","article-title":"Identification and management of alcohol withdrawal syndrome","volume":"75","author":"Mirijello","year":"2015","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.psym.2018.03.002_bib10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jemermed.2012.07.056","article-title":"Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study","volume":"44","author":"Rosenson","year":"2013","journal-title":"J Emerg Med"},{"issue":"2","key":"10.1016\/j.psym.2018.03.002_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/08897070309511541","article-title":"Gabapentin for the treatment of ethanol withdrawal","volume":"24","author":"Voris","year":"2003","journal-title":"Subst Abus"},{"issue":"8","key":"10.1016\/j.psym.2018.03.002_bib12","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1177\/1060028015585849","article-title":"The role of gabapentin in the management of alcohol withdrawal and dependence","volume":"49","author":"Leung","year":"2015","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.psym.2018.03.002_bib13","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ccc.2017.03.012","article-title":"Novel algorithms for the prophylaxis and management of alcohol withdrawal syndromes-beyond benzodiazepines","volume":"33","author":"Maldonado","year":"2017","journal-title":"Crit Care Clin"},{"issue":"8","key":"10.1016\/j.psym.2018.03.002_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1592\/phco.2005.25.8.1073","article-title":"Experience with an adult alcohol withdrawal syndrome practice guideline in internal medicine patients","volume":"25","author":"Stanley","year":"2005","journal-title":"Pharmacotherapy"},{"issue":"8","key":"10.1016\/j.psym.2018.03.002_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1001\/archotol.134.8.865","article-title":"Improved outcomes in patients with head and neck cancer using a standardized care protocol for postoperative alcohol withdrawal","volume":"134","author":"Lansford","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.1016\/j.psym.2018.03.002_bib16","first-page":"70","article-title":"Gabapentin treatment for alcohol dependence: a randomized clinical trial","volume":"174","author":"Mason","year":"2014","journal-title":"J Am Med Assoc Intern Med"},{"issue":"5","key":"10.1016\/j.psym.2018.03.002_bib17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/alcalc\/agv043","article-title":"Prospective validation study of the Prediction of Alcohol Withdrawal Severity scale (PAWSS) in medically ill inpatients: a new scale for the prediction of complicated alcohol withdrawal syndrome","volume":"50","author":"Maldonado","year":"2015","journal-title":"Alcohol Alcohol"},{"issue":"3","key":"10.1016\/j.psym.2018.03.002_bib18","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0741-8329(89)90022-0","article-title":"Prevention of alcohol withdrawal seizures with carbamazepine and valproic acid","volume":"6","author":"Hillbom","year":"1989","journal-title":"Alcohol"},{"issue":"1","key":"10.1016\/j.psym.2018.03.002_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14423\/SMJ.0000000000000216","article-title":"Implementation of a CIWA-Ar alcohol withdrawal protocol in a veterans hospital","volume":"108","author":"Waye","year":"2015","journal-title":"South Med J"},{"issue":"6","key":"10.1016\/j.psym.2018.03.002_bib20","doi-asserted-by":"crossref","first-page":"559","DOI":"10.18553\/jmcp.2003.9.6.559","article-title":"Examination of the evidence for off-label use of gabapentin","volume":"9","author":"Mack","year":"2003","journal-title":"J Manag Care Pharm"},{"issue":"19","key":"10.1016\/j.psym.2018.03.002_bib21","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.2174\/138161210791516468","article-title":"Medications acting on the GABA system in the treatment of alcoholic patients","volume":"16","author":"Caputo","year":"2010","journal-title":"Curr Pharm Des"},{"issue":"7-8","key":"10.1016\/j.psym.2018.03.002_bib22","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1345\/aph.1R751","article-title":"Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment","volume":"47","author":"Stock","year":"2013","journal-title":"Ann Pharmacother"},{"issue":"9","key":"10.1016\/j.psym.2018.03.002_bib23","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1111\/j.1530-0277.2009.00986.x","article-title":"A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal","volume":"33","author":"Myrick","year":"2009","journal-title":"Alcohol Clin Exp Res"}],"container-title":["Psychosomatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318218301385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033318218301385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T17:42:07Z","timestamp":1660671727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033318218301385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0033318218301385"],"URL":"https:\/\/doi.org\/10.1016\/j.psym.2018.03.002","relation":{},"ISSN":["0033-3182"],"issn-type":[{"value":"0033-3182","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of a Gabapentin Protocol for the Management of Alcohol Withdrawal: A Preliminary Experience Expanding From the Consultation-Liaison Psychiatry Service","name":"articletitle","label":"Article Title"},{"value":"Psychosomatics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psym.2018.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}